1. Abrahamsson PA, Falkner S, Falt K, Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas: an immunohistochemical study testing chromogranin A as an 'endocrinemarker'. Pathol Res Pract 1989; 185:3 73-80;
2. Baisden BL, Kahane H, Epstein JI: Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy. Am J Surg Pathol 1999, 23: 918-924;
3. Beahrs OH, Henson DE, Hutter RP, Kennedy BJ. American Joint Committee on Cancer staging manual for staging of cancer, 4th edn. Philadelphia, PA: Lippincott, 1992;
4. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol, 1993; 24: 298-310;
5. Bostwick DG, Grignon DJ, Hammond ME, Amin MB, Cohen M, Crawford D,Go-spodarowicz M, Kaplan RS, Miller DS, Montironi R, Pajak TF, Pollack A, Srigley JR, Yarbro JW: Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124: 995-1000;